What is Tailor Made Compounding?
Operating as a sophisticated 503A compounding pharmacy, Tailor Made Compounding occupies a critical niche in the healthcare ecosystem by bridging the gap between standardized pharmaceutical manufacturing and individualized patient requirements. The firm specializes in high-demand therapeutic areas, including hormone replacement therapy and peptide-based treatments. By maintaining robust partnerships with healthcare providers, the company facilitates a collaborative care model that prioritizes bespoke wellness outcomes. Their infrastructure is designed to support both clinical practices and individual patients, ensuring that specialized formulations are accessible, compliant, and effective in addressing complex health needs that off-the-shelf medications often fail to resolve.
How much funding has Tailor Made Compounding raised?
Tailor Made Compounding has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Tailor Made Compounding
PPP
Public-Private Partnership
What's next for Tailor Made Compounding?
With this latest round of financing, Tailor Made Compounding is well-positioned to accelerate its operational expansion and deepen its investment in pharmaceutical research and development. The company is expected to leverage this capital to enhance its compounding capabilities, potentially integrating advanced automation to maintain quality control while scaling production. Furthermore, the strategic focus will likely shift toward expanding its educational outreach to clinics, thereby solidifying its role as a preferred partner for practitioners seeking to offer comprehensive, patient-specific wellness solutions. As the regulatory landscape for compounding pharmacies continues to evolve, the firm's commitment to compliance and high-standard manufacturing will be a key differentiator in maintaining its competitive edge in the personalized medicine market.
See full Tailor Made Compounding company page
